The HFH Hermelin Brain Tumor Center has participated in the New Applications in Brain Tumor Therapy [Johns Hopkins University] (NABTT) consortium since its inception as a research and clinical trials group in 1993. We have been a productive and integral member contributing to its success, as demonstrated by our accrual and data quality awards. We continue to aggressively pursue state-of-the-art surgical, radiation and medical therapies for our patients, to improve methods for longitudinal follow-up using neuroimaging, and pursue active research in the laboratory for new diagnostic, therapeutic and prognostic tools. These efforts speak to the ultimate goal of our group and NABTT Consortium: improving the outcome of brain tumor patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA062432-11
Application #
6927206
Study Section
Special Emphasis Panel (ZCA1-SRRB-E (O2))
Program Officer
Ullmann, Claudio A
Project Start
1998-01-01
Project End
2008-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
11
Fiscal Year
2005
Total Cost
$133,646
Indirect Cost
Name
Henry Ford Health System
Department
Neurosurgery
Type
Schools of Medicine
DUNS #
073134603
City
Detroit
State
MI
Country
United States
Zip Code
48202
Mikkelsen, T; Yan, P S; Ho, K L et al. (1995) Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J Neurosurg 83:285-90
Rempel, S A; Rosenblum, M L; Mikkelsen, T et al. (1994) Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 54:6027-31